Objective Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's disease
(AD), would aggravate cognitive dysfunction. This study aimed to investigate whether and to …

Background: Recent studies have reported that homocysteine (Hcy) may play a vital role in
the pathogenesis of vascular dementia (VaD) and Alzheimer's disease (AD). Our study …

Objective To investigate whether high serum homocysteine (Hcy) levels is associated with
the risk of developing Alzheimer's disease (AD) by performing a meta-analysis based on …

The associations between homocysteine (Hcy), folic acid, and vitamin B12 and Alzheimer's
disease (AD) have gained much interest, while remaining controversial. We aim to perform …

Hyperhomocysteinemia (HHcy) is supposed to be one of the modifiable risk factors that, if
treated, may delay the onset of Alzheimer's disease (AD). The relation between serum …

Background Growing evidence suggests that hyperhomocysteinemia (HHcy) constitutes a
risk factor for Alzheimer's Disease (AD). The impact of HHcy on cognitive functions has …

BACKGROUND: Prospective cohort studies have not been consistent in showing an
association between serum homocysteine and dementia. OBJECTIVE: To conduct a meta …

Homocysteine (Hcy) is a risk factor for brain atrophy, cognitive impairment, and dementia.
Vitamin B12 and folate are cofactors necessary for the methylation of Hcy. However, there is …

Abstract Objectives Hyperhomocysteinemia in Alzheimer's disease (AD) is widely reported
and appears to worsen as the disease progresses. While active dietary intervention with …

Background: There is a growing focus on nutritional therapy for Alzheimer's disease (AD),
and controversy exists regarding the association between AD and homocysteine (Hcy) …